Recent News Articles


Private Eye Investigator

COVID-19 NOW: Novel Therapeutics and How to Find Them

For those of us living with cancer, this is what being proactive looks like right now in 4 steps. Because this is no time to lower your defenses.


Public Health on Fire

Cancer, Like COVID: A Public Health Failure

Ed Yong’s recent sobering piece in The Atlantic on the U.S.’s lack of preparedness for the next pandemic that’s inevitably “barreling toward us”  hit my inbox with a ‘must read’ thud. Cogently written, it provides historical context for the myriad errors committed—and how the many lessons learned early on with COVID were somehow not actionable for the next episode of death: the Delta variant.


Fresh fruit slices

Carcinogenic, Hormone-Disrupting Fungicides Found on Citrus Fruit

A recent investigation commissioned by the Environmental Working Group identified imazalil and thiabendazole on nearly 90 percent of non-organic citrus fruit samples.


All Vaxxed Up and Nowhere to Go: Cancer Patients and the Whole Damn Dilemma

Recent studies show approximately one in four blood cancer patients fail to produce detectable antibodies after COVID-19 vaccination. This is most prevalent in those hosting non-Hodgkin lymphomas and chronic lymphocytic leukemia, but also in those hosting multiple myeloma and other blood cancers.


Top Clinical Cancer Advances 2021 (During a Pandemic)

Advanced cancer care is the cornerstone of integrative oncology. Without conventional care, integrative oncology and lifestyle modifications are not complete. Here are the latest advances in cancer care during 2020.


Early morning runner

Rise and Move! Morning Exercise May Prevent Cancer

Compelling new study indicates that the time of day we participate in physical activity can help fend off cancer.


Green leaf close-up texture

Chemo-Free Treatment Best Option for CLL Patients Under 70

There is good news in the advancement of chemo-free approaches to managing chronic lymphocytic leukemia, and I am thrilled to share it with you. Results of the phase III ECOG trial found that the combination of ibrutinib (Imbruvica) plus rituximab (Rituxan) came out superior to the chemotherapy and immunotherapy (chemoimmunotherapy) grouping of fludarabine, cyclophosphamide, and rituximab, known as FCR.


Stack of JAMA Oncology Journals

Does ‘Complementary Medicine’ in Cancer Care Cause Early Death?

A recently published paper in the esteemed JAMA Oncology triggered dire headlines, including this one in The New York Times:
“People who used herbs, acupuncture and other complementary treatments tended to die earlier than those who didn’t.”
Really? Is this true?


Right-toTry Bill - logo

Cancer Treatment ‘Right-to-Try’ Bill: Pros, Cons, Unknowns

The Right-to-Try movement—advocates for faster access to potentially life-saving experimental drugs for terminal patients—has gained strong momentum, with the act recently winning easy passage in congress, and, at the time of this article, it is on its way for a senate vote. The legislation is widely anticipated to become law later this year. As of […]


3D cover of guide: 10 Essentials to Taking Control of Your Cancer Journey

[Free Guide] 10 Essential Steps to Take Control of Your Cancer Journey

n of 1 author Glenn Sabin offers 10 important steps to take immediate control of your cancer journey, and to position you at the center of your own care.